Amyloid-beta-IN-1 (compound 13) is a synthetic peptide containing the hydrophobic C-terminal region VVIA-NH2 and its reverse sequence AIVV-NH2 of Abeta42, which is an Abeta inhibitor. Amyloid-beta-IN-1 can inhibit Abeta aggregation and has neuroprotective effects[1].
Molecular Weight:
385.50
Formula:
C18H35N5O4
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
